It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
From February to April 2020, Lombardy (Italy) reported the highest numbers of SARS-CoV-2 cases worldwide. By analyzing 346 whole SARS-CoV-2 genomes, we demonstrate the presence of seven viral lineages in Lombardy, frequently sustained by local transmission chains and at least two likely to have originated in Italy. Six single nucleotide polymorphisms (five of them non-synonymous) characterized the SARS-CoV-2 sequences, none of them affecting N-glycosylation sites. The seven lineages, and the presence of local transmission clusters within three of them, revealed that sustained community transmission was underway before the first COVID-19 case had been detected in Lombardy.
The Lombardy region of Italy was heavily affected early in the SARS-CoV-2 pandemic. Here, the authors use whole genome sequencing and show that there were multiple introductions into the region, with transmission occurring before the first case was detected.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Cento Valeria 1 ; Piralla Antonio 2
; Costabile Valentino 3
; Tallarita Monica 2 ; Luna, Colagrossi 4 ; Renica Silvia 1 ; Giardina Federica 2 ; Novazzi Federica 2 ; Gaiarsa Stefano 2 ; Matarazzo Elisa 5 ; Antonello, Maria 1 ; Vismara Chiara 6 ; Fumagalli, Roberto 7 ; Epis, Oscar Massimiliano 8 ; Puoti Massimo 9 ; Perno, Carlo Federico 4
; Baldanti Fausto 10 1 University of Milan, Department of Oncology and Hemato-oncology, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
2 Fondazione IRCCS Policlinico San Matteo, Molecular Virology Unit, Microbiology and Virology Department, Pavia, Italy (GRID:grid.419425.f) (ISNI:0000 0004 1760 3027)
3 University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
4 Bambino Gesù Children’s Hospital, IRCCS, Microbiology and Diagnostic Immunology Unit, Rome, Italy (GRID:grid.414125.7) (ISNI:0000 0001 0727 6809)
5 University of Milan, Residency in Microbiology and Virology, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
6 ASST Grande Ospedale Metropolitano Niguarda, Chemico-clinical and Microbiological Analyses, Milan, Italy (GRID:grid.4708.b)
7 Department of Anesthesiology, Critical Care and Pain Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy (GRID:grid.4708.b)
8 Rheumatology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy (GRID:grid.4708.b)
9 ASST Grande Ospedale Metropolitano Niguarda, Infectious Diseases Unit, Milan, Italy (GRID:grid.4708.b)
10 Fondazione IRCCS Policlinico San Matteo, Molecular Virology Unit, Microbiology and Virology Department, Pavia, Italy (GRID:grid.419425.f) (ISNI:0000 0004 1760 3027); University of Pavia, Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, Pavia, Italy (GRID:grid.8982.b) (ISNI:0000 0004 1762 5736)




